The ascendancy of Viagra and its influence on the drug landscape presents a complex question for shareholders. While the first sales data were astounding, the patent has expired, leading to a wave of off-brand https://geraldtshn170045.blogdomago.com/39894963/the-blue-pill-and-big-pharma-a-risky-opportunity